Model
Edge
BioCryst Pharmaceuticals Inc
0001760020
Filing Type
144
Filing Date
8/12/2025
Updated
8/13/25, 10:17 AM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities